Pilotto syndrome is a rare syndrome which affects the face, heart, and back. The syndrome can cause a cleft lip and palate, scoliosis, and mental retardation. The Office of Rare Diseases and National Institutes of Health have classified this syndrome as affecting less than 200,000 people in the United States. References


== External links ==
Daypro by Searle is listed as the Reference Listed Drug to prove the bioequivalence of the ANDAs. Below is a table listing all of the approved oxaprozin products. Recalls
Advantage Dose LLC recalled oxaprozin tablets on November 26, 2008. The company was not in conformance with cGMP. (Recall #D-837-2009)


== References ==